nitroblue tetrazolium has been researched along with Myelodysplastic Syndromes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, K; Matsuoka, A; Nagano, S; Umemoto, M | 1 |
1 other study(ies) available for nitroblue tetrazolium and Myelodysplastic Syndromes
| Article | Year |
|---|---|
[Flow cytometric measurement of NBT-reducing activity in peripheral leukocytes applying THMS H.1TM].
Topics: Flow Cytometry; Humans; Leukocytes; Myelodysplastic Syndromes; Nitroblue Tetrazolium; Oxidation-Reduction; Phagocytes; Superoxides; Tetrazolium Salts | 1990 |